老年心力衰竭患者的综合用药:老年医学专家和药剂师的角色。

IF 4.2 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
Maria Stefil, Matthew Dixon, Jameela Bahar, Schabnam Saied, Knievel Mashida, Olivia Heron, Eduard Shantsila, Lauren Walker, Asangaedem Akpan, Gregory Yh Lip, Rajiv Sankaranarayanan
{"title":"老年心力衰竭患者的综合用药:老年医学专家和药剂师的角色。","authors":"Maria Stefil,&nbsp;Matthew Dixon,&nbsp;Jameela Bahar,&nbsp;Schabnam Saied,&nbsp;Knievel Mashida,&nbsp;Olivia Heron,&nbsp;Eduard Shantsila,&nbsp;Lauren Walker,&nbsp;Asangaedem Akpan,&nbsp;Gregory Yh Lip,&nbsp;Rajiv Sankaranarayanan","doi":"10.15420/cfr.2022.14","DOIUrl":null,"url":null,"abstract":"<p><p>Heart failure (HF) is a common health condition that typically affects older adults. Many people with HF are cared for on an inpatient basis, by noncardiologists, such as acute medical physicians, geriatricians and other physicians. Treatment options for HF are ever increasing, and adherence to guidelines for prognostic therapy contributes to polypharmacy, which is very familiar to clinicians who care for older people. This article explores the recent trials in both HF with reduced ejection fraction and HF with preserved ejection fraction and the limitations of international guidance in their management with respect to older people. In addition, this article discusses the challenge of managing polypharmacy in those with advanced age, and the importance of involving a geriatrician and pharmacist in the HF multidisciplinary team to provide a holistic and person-centred approach to optimisation of HF therapies.</p>","PeriodicalId":33741,"journal":{"name":"Cardiac Failure Review","volume":"8 ","pages":"e34"},"PeriodicalIF":4.2000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/57/55/cfr-08-e34.PMC9987511.pdf","citationCount":"0","resultStr":"{\"title\":\"Polypharmacy in Older People With Heart Failure: Roles of the Geriatrician and Pharmacist.\",\"authors\":\"Maria Stefil,&nbsp;Matthew Dixon,&nbsp;Jameela Bahar,&nbsp;Schabnam Saied,&nbsp;Knievel Mashida,&nbsp;Olivia Heron,&nbsp;Eduard Shantsila,&nbsp;Lauren Walker,&nbsp;Asangaedem Akpan,&nbsp;Gregory Yh Lip,&nbsp;Rajiv Sankaranarayanan\",\"doi\":\"10.15420/cfr.2022.14\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Heart failure (HF) is a common health condition that typically affects older adults. Many people with HF are cared for on an inpatient basis, by noncardiologists, such as acute medical physicians, geriatricians and other physicians. Treatment options for HF are ever increasing, and adherence to guidelines for prognostic therapy contributes to polypharmacy, which is very familiar to clinicians who care for older people. This article explores the recent trials in both HF with reduced ejection fraction and HF with preserved ejection fraction and the limitations of international guidance in their management with respect to older people. In addition, this article discusses the challenge of managing polypharmacy in those with advanced age, and the importance of involving a geriatrician and pharmacist in the HF multidisciplinary team to provide a holistic and person-centred approach to optimisation of HF therapies.</p>\",\"PeriodicalId\":33741,\"journal\":{\"name\":\"Cardiac Failure Review\",\"volume\":\"8 \",\"pages\":\"e34\"},\"PeriodicalIF\":4.2000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/57/55/cfr-08-e34.PMC9987511.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cardiac Failure Review\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15420/cfr.2022.14\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiac Failure Review","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15420/cfr.2022.14","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

心力衰竭(HF)是一种常见的健康状况,通常影响老年人。许多心衰患者是由非心脏病专家,如急症内科医生、老年病医生和其他医生在住院治疗。心衰的治疗选择不断增加,对预后治疗指南的遵守有助于多药治疗,这对于照顾老年人的临床医生来说是非常熟悉的。本文探讨了最近针对射血分数降低的心衰和保留射血分数的心衰的试验,以及针对老年人的国际指导管理的局限性。此外,本文还讨论了在高龄患者中管理多种药物治疗的挑战,以及在心衰多学科团队中涉及老年病专家和药剂师的重要性,以提供一个整体的、以人为本的方法来优化心衰治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Polypharmacy in Older People With Heart Failure: Roles of the Geriatrician and Pharmacist.

Polypharmacy in Older People With Heart Failure: Roles of the Geriatrician and Pharmacist.

Heart failure (HF) is a common health condition that typically affects older adults. Many people with HF are cared for on an inpatient basis, by noncardiologists, such as acute medical physicians, geriatricians and other physicians. Treatment options for HF are ever increasing, and adherence to guidelines for prognostic therapy contributes to polypharmacy, which is very familiar to clinicians who care for older people. This article explores the recent trials in both HF with reduced ejection fraction and HF with preserved ejection fraction and the limitations of international guidance in their management with respect to older people. In addition, this article discusses the challenge of managing polypharmacy in those with advanced age, and the importance of involving a geriatrician and pharmacist in the HF multidisciplinary team to provide a holistic and person-centred approach to optimisation of HF therapies.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
5.60
自引率
0.00%
发文量
31
审稿时长
9 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信